Drug Infusion System Market Research Report, by Product Type (Elastomeric Infusion System, Disposable Infusion System), by Application (Oncology/Chemotherapy), Mode of Administration (Intravenous), End-User (Hospitals) - Forecast Till 2032

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Drug infusion system Market, by Product Type

6.1 Introduction

6.2 Elastomeric infusion system

6.3 Disposable infusion system

6.4 Syringe infusion system

6.5 Peristaltic pump

6.6 Multi-channel pump

6.7 Patient-controlled analgesia (PCA) pump

6.8 Insulin pump

6.9 Implantable infusion system

Chapter 7. Global Drug infusion system Market, by Application

7.1 Introduction

7.2 Oncology/Chemotherapy

7.3 Diabetes

7.4 Analgesia

7.5 Nutrition

7.6 Hematology

7.7 Pediatrics

7.8 Others

Chapter 8. Global Drug infusion system Market, by Mode of administration

8.1 Introduction

8.2 Intravenous

8.3 Subcutaneous

8.4 Arterial

8.5 Epidural

8.6 Others

Chapter 10. Global Drug infusion system Market, by End-User

10.1 Introduction

10.2 Hospitals

10.3 Ambulatory Surgical Centers

10.4 Diagnostic centers

10.5 Others

Chapter 11. Global Drug infusion system Market, by Region

11.1 Introduction

11.2 America

11.2.1 North America

11.2.1.1 US

11.2.1.2 Canada

11.2.2 South America

11.3 Europe

11.3.1 Western Europe

11.3.1.1 Germany

11.3.1.2 France

11.3.1.3 Italy

11.3.1.4 Spain

11.3.1.5 UK

11.3.1.6 Rest of Western Europe

11.3.2 Eastern Europe

11.4 Asia-Pacific

11.4.1 Japan

11.4.2 China

11.4.3 India

11.4.4 Australia

11.4.5 Republic of Korea

11.4.6 Rest of Asia-Pacific

11.5 The Middle East & Africa

11.5.1 United Arab Emirates

11.5.2 Saudi Arabia

11.5.3 Oman

11.5.4 Kuwait

11.5.5 Qatar

11.5.6 Rest of the Middle East & Africa

Chapter 12. Company Landscape

12.1 Introduction

12.2 Market Share Analysis

12.3 Key Development & Strategies

12.3.1 Key Developments

Chapter 13 Company Profiles

13.1 MEDTRONIC

13.1.1 Company Overview

13.1.2 Type Overview

13.1.3 Financials

13.2.4 Key Developments

13.1.5 SWOT Analysis

13.2 Arcomed AG

13.2.1 Company Overview

13.2.2 Type Overview

13.2.3 Financial Overview

13.2.4 Key Developments

13.2.5 SWOT Analysis

13.3 B. Braun Melsungen AG

13.3.1 Company Overview

13.3.2 Type Overview

13.3.3 Financial Overview

13.3.4 Key Development

13.3.5 SWOT Analysis

13.4 Baxter

13.4.1 Company Overview

13.4.2 Type/Business Segment Overview

13.4.3 Financial Overview

13.4.4 Key Development

13.4.5 SWOT Analysis

13.5 Debiotech S.A.

13.5.1 Company Overview

13.5.2 Type Overview

13.5.3 Financial overview

13.5.4 Key Developments

13.5.5 SWOT Analysis

13.6 Fresenius SE & Co. KGaA

13.6.1 Company Overview

13.6.2 Type Overview

13.6.3 Financial Overview

13.6.4 Key Developments

13.6.5 SWOT Analysis

13.7 BECTON DICKINSON AND COMPANY

13.7.1 Overview

13.7.2 Type Overview

13.7.3 Financials

13.7.4 Key Developments

13.7.5 SWOT Analysis

13.8 Halyard Health, Inc

13.8.1 Overview

13.8.2 Type Overview

13.8.3 Financials

13.8.4 Key Developments

13.8.5 SWOT Analysis

13.9 ICU Medical Inc

13.9.1 Overview

13.9.2 Type Overview

13.9.3 Financials

13.9.4 Key Developments

13.9.5 SWOT Analysis

13.10 IRadimed Corporation

13.10.1 Overview

13.10.2 Type Overview

13.10.3 Financials

13.10.4 Key Developments

13.10.5 SWOT Analysis

13.11 Insulet Corporation

13.11.1 Overview

13.11.2 Type Overview

13.11.3 Financials

13.11.4 Key Developments

13.11.5 SWOT Analysis

13.12 Terumo Corporation

13.12.1 Overview

13.12.2 Type Overview

13.12.3 Financials

13.12.4 Key Developments

13.12.5 SWOT Analysis

13.13 Smiths Group plc

13.13.1 Overview

13.13.2 Type Overview

13.13.3 Financials

13.13.4 Key Developments

13.13.5 SWOT Analysis

13.14 Tandem Diabetes care

13.14.1 Overview

13.14.2 Type Overview

13.14.3 Financials

13.14.4 Key Developments

13.14.5 SWOT Analysis

13.15 MOOG INC

13.15.1 Overview

13.15.2 Type Overview

13.15.3 Financials

13.15.4 Key Developments

13.15.5 SWOT Analysis

13.16 Others

Chapter 14 Appendix

LIST OF TABLES

Table 1 Drug infusion system Market Industry Synopsis, 2020-2027

Table 2 Global Drug infusion system Market Estimates & Forecast, 2020-2027, (USD Million)

Table 3 Global Drug infusion system Market, by Region, 2020-2027, (USD Million)

Table 4 Global Drug infusion system Market, by Product Type, 2020-2027, (USD Million)

Table 6 Global Drug infusion system Market, by Mode of Administration, 2020-2027, (USD Million)

Table 7 Global Drug infusion system Market, by Application, 2020-2027, (USD Million)

Table 8 Global Drug infusion system Market, by End-User, 2020-2027, (USD Million

Table 9 North America Drug infusion system Market, by Product Type, 2020-2027, (USD Million)

Table 11 North America Drug infusion system Market, by Mode of Administration, 2020-2027, (USD Million)

Table 12 North America Drug infusion system Market, by Application, 2020-2027, (USD Million)

Table 13 North America Drug infusion system Market, by End-User, 2020-2027, (USD Million)

Table 14 US Drug infusion system Market, by Product Type, 2020-2027, (USD Million)

Table 16 US Drug infusion system Market, by Mode of Administration, 2020-2027, (USD Million)

Table 17 US Drug infusion system Market, by Application, 2020-2027, (USD Million)

Table 18 US Drug infusion system Market, by End-User, 2020-2027, (USD Million)

Table 19 Canada Drug infusion system Market, by Product Type, 2020-2027, (USD Million)

Table 21 Canada Drug infusion system Market, by Mode of Administration, 2020-2027, (USD Million)

Table 22 Canada Drug infusion system Market, by Application, 2020-2027, (USD Million)

Table 23 Canada Drug infusion system Market, by End-User, 2020-2027, (USD Million)

Table 24 South America Drug infusion system Market, by Product Type, 2020-2027, (USD Million)

Table 26 South America Drug infusion system Market, by Mode of Administration, 2020-2027, (USD Million)

Table 27 South America Drug infusion system Market, by Application, 2020-2027, (USD Million)

Table 28 South America Drug infusion system Market, by End-User, 2020-2027, (USD Million)

Table 31 Europe Drug infusion system Market, Mode of Administration, 2020-2027, (USD Million)

Table 32 Europe Drug infusion system Market, by Application, 2020-2027, (USD Million)

Table 33 Europe Drug infusion system Market, by End-User, 2020-2027, (USD Million)

Table 34 Western Europe Drug infusion system Market, by Product Type, 2020-2027, (USD Million)

Table 36 Western Europe Drug infusion system Market, by Mode of Administration, 2020-2027, (USD Million)

Table 37 Western Europe Drug infusion system Market, by Application, 2020-2027, (USD Million)

Table 38 Western Europe Drug infusion system Market, by End-User, 2020-2027, (USD Million)

Table 39 Eastern Europe Drug infusion system Market, by Product Type, 2020-2027, (USD Million)

Table 41 Eastern Europe Drug infusion system Market, by Mode of Administration, 2020-2027, (USD Million)

Table 42 Eastern Europe Drug infusion system Market, by Application, 2020-2027, (USD Million)

Table 43 Eastern Europe Drug infusion system Market, by End-User, 2020-2027, (USD Million)

Table 44 Asia-Pacific Drug infusion system Market, by Product Type, 2020-2027, (USD Million)

Table 46 Asia-Pacific Drug infusion system Market, by Mode of Administration, 2020-2027, (USD Million)

Table 47 Asia-Pacific Drug infusion system Market, by Application, 2020-2027, (USD Million)

Table 48 Asia-Pacific Drug infusion system Market, by End-User, 2020-2027, (USD Million)

Table 49 The Middle East & Africa Drug infusion system Market, by Product Type, 2020-2027, (USD Million)

Table 51 The Middle East & Africa Drug infusion system Market, by Mode of Administration, 2020-2027, (USD Million)

Table 52 The Middle East & Africa Drug infusion system Market, by Application, 2020-2027, (USD Million)

Table 53 The Middle East & Africa Drug infusion system Market, by End-User, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Drug infusion system Market

Figure 3 Market Dynamics for Global Drug infusion system Market

Figure 4 Global Drug infusion system Market Share, by Product Type 2020

Figure 5 Global Drug infusion system Market Share, by Application 2020

Figure 5 Global Drug infusion system Market Share, by Mode of administration 2020

Figure 6 Global Drug infusion system Market Share, by End-User, 2020

Figure 7 Global Drug infusion system Market Share, by Region, 2020

Figure 8 North America Drug infusion system Market Share, by Country, 2020

Figure 9 Europe Drug infusion system Market Share, by Country, 2020

Figure 10 Asia-Pacific Drug infusion system Market Share, by Country, 2020

Figure 11 Middle East & Africa Drug infusion system Market Share, by Country, 2020

Figure 12 Global Drug infusion system Market: Company Share Analysis, 2020 (%)

Figure 13 MEDTRONIC: Key Financials

Figure 14 MEDTRONIC: Segmental Revenue

Figure 15 MEDTRONIC: Geographical Revenue

Figure 16 Arcomed AG: Key Financials

Figure 17 Arcomed AG: Segmental Revenue

Figure 18 Arcomed AG: Geographical Revenue

Figure 19 B. Braun Melsungen AG: Key Financials

Figure 20 B. Braun Melsungen AG: Segmental Revenue

Figure 21 B. Braun Melsungen AG: Geographical Revenue

Figure 22 Baxter: Key Financials

Figure 23 Baxter: Segmental Revenue

Figure 24 Baxter: Geographical Revenue

Figure 25 Fresenius SE & Co. KGaA: Key Financials

Figure 26 Fresenius SE & Co. KGaA: Segmental Revenue

Figure 27 Fresenius SE & Co. KGaA: Geographical Revenue

Figure 28 Debiotech S.A.: Key Financials

Figure 29 Debiotech S.A.: Segmental Revenue

Figure 30 Debiotech S.A.: Geographical Revenue

Figure 31 BECTON DICKINSON AND COMPANY: Key Financials

Figure 32 BECTON DICKINSON AND COMPANY: Segmental Revenue

Figure 33 BECTON DICKINSON AND COMPANY: Geographical Revenue

Figure 34 Halyard Health, Inc: Key Financials

Figure 35 Halyard Health, Inc: Segmental Revenue

Figure 36 Halyard Health, Inc: Geographical Revenue

Figure 37 ICU Medical Inc: Key Financials

Figure 38 ICU Medical Inc: Segmental Revenue

Figure 39 ICU Medical Inc: Geographical Revenue

Figure 40 IRadimed Corporation: Key Financials

Figure 41 IRadimed Corporation: Segmental Revenue

Figure 42 IRadimed Corporation: Geographical Revenue

Figure 40 Insulet Corporation: Key Financials

Figure 41 Insulet Corporation: Segmental Revenue

Figure 42 Insulet Corporation: Geographical Revenue

Figure 43 MOOG INC: Key Financials

Figure 44 MOOG INC: Segmental Revenue

Figure 45 MOOG INC: Geographical Revenue

Figure 46 Terumo Corporation: Key Financials

Figure 47 Terumo Corporation: Segmental Revenue

Figure 48 Terumo Corporation: Geographical Revenue

Figure 49 Smiths Group plc: Key Financials

Figure 50 Smiths Group plc: Segmental Revenue

Figure 51 Smiths Group plc: Geographical Revenue

Figure 52 Tandem Diabetes care: Key Financials

Figure 53 Tandem Diabetes care: Segmental Revenue

Figure 54 Tandem Diabetes care: Geographical Revenue